Low-Cost Platelet-Rich Plasma for Hemarthropathy

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 23, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2026

Conditions
HemarthrosisHemophilia
Interventions
BIOLOGICAL

Intra articular PRP Injection

A total of 20 joints (estimated 10-15 patients) will receive injections, performed at day 0 and 3 weeks, for a total of two injections - two injections have demonstrated superior outcomes to one, and will increase our number of injections to improve the proof of feasibility. All subjects will receive ultrasound-guided intra-articular joint injections by an experienced sports medicine provider after local anesthesia with 1% lidocaine to the extra-articular structures, namely the skin and joint capsule, to increase comfort.

Trial Locations (1)

84108

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT06543368 - Low-Cost Platelet-Rich Plasma for Hemarthropathy | Biotech Hunter | Biotech Hunter